These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16540757)

  • 61. Two different types of renal involvement in tuberous sclerosis complex.
    Scolari F; Viola BF; Grazioli L; Longa L; Migone N; Maiorca R
    Contrib Nephrol; 2001; (136):318-24. PubMed ID: 11688400
    [No Abstract]   [Full Text] [Related]  

  • 62. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
    Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
    Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Three independent mutations in the TSC2 gene in a family with tuberous sclerosis.
    Le Caignec C; Kwiatkowski DJ; Küry S; Hardouin JB; Melki J; David A
    Eur J Hum Genet; 2009 Sep; 17(9):1165-70. PubMed ID: 19259131
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of PKD1 for genomic deletion by multiplex ligation-dependent probe assay: absence of hot spots.
    Kozlowski P; Bissler J; Pei Y; Kwiatkowski DJ
    Genomics; 2008 Feb; 91(2):203-8. PubMed ID: 18060739
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TSC2, a key player in tumor suppression and cystic kidney disease.
    Cai SL; Walker CL
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S119-22. PubMed ID: 17373211
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tuberous sclerosis-related gene expression in normal and dysplastic brain.
    Vinters HV; Kerfoot C; Catania M; Emelin JK; Roper SN; DeClue JE
    Epilepsy Res; 1998 Sep; 32(1-2):12-23. PubMed ID: 9761305
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TSC2/PKD1 contiguous gene síndrome.
    Cammarata-Scalisi F; Vidales Moreno C; Zara-Chirinos C; Bracho A; Pérez D
    Nefrologia; 2017; 37(6):663-665. PubMed ID: 29122219
    [No Abstract]   [Full Text] [Related]  

  • 69. Complete inactivation of the TSC2 gene leads to formation of hamartomas.
    Au KS; Hebert AA; Roach ES; Northrup H
    Am J Hum Genet; 1999 Dec; 65(6):1790-5. PubMed ID: 10577937
    [No Abstract]   [Full Text] [Related]  

  • 70. Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.
    Au KS; Rodriguez JA; Finch JL; Volcik KA; Roach ES; Delgado MR; Rodriguez E; Northrup H
    Am J Hum Genet; 1998 Feb; 62(2):286-94. PubMed ID: 9463313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
    Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ
    Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Diagnosis of tuberous sclerosis complex focusing on prenatal period].
    Filipová H; Procházka M; Vrtěl R
    Ceska Gynekol; 2016 Apr; 81(2):147-54. PubMed ID: 27457398
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex.
    Santiago Lima AJ; Hoogeveen-Westerveld M; Nakashima A; Maat-Kievit A; van den Ouweland A; Halley D; Kikkawa U; Nellist M
    PLoS One; 2014; 9(4):e93940. PubMed ID: 24714658
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.
    Avgeris S; Fostira F; Vagena A; Ninios Y; Delimitsou A; Vodicka R; Vrtel R; Youroukos S; Stravopodis DJ; Vlassi M; Astrinidis A; Yannoukakos D; Voutsinas GE
    Sci Rep; 2017 Dec; 7(1):16697. PubMed ID: 29196670
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds.
    Wentink M; Nellist M; Hoogeveen-Westerveld M; Zonnenberg B; van der Kolk D; van Essen T; Park SM; Woods G; Cohn-Hokke P; Brussel W; Smeets E; Brooks A; Halley D; van den Ouweland A; Maat-Kievit A
    Clin Genet; 2012 May; 81(5):453-61. PubMed ID: 21332470
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tuberous sclerosis complex: from Drosophila to human disease.
    Pan D; Dong J; Zhang Y; Gao X
    Trends Cell Biol; 2004 Feb; 14(2):78-85. PubMed ID: 15102439
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tuberous sclerosis: diagnosis and prenatal diagnosis by MLPA.
    Padma Priya T; Dalal AB
    Indian J Pediatr; 2012 Oct; 79(10):1366-9. PubMed ID: 21541650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Generation of a transcriptional map for a 700-kb region surrounding the polycystic kidney disease type 1 (PKD1) and tuberous sclerosis type 2 (TSC2) disease genes on human chromosome 16p3.3.
    Burn TC; Connors TD; Van Raay TJ; Dackowski WR; Millholland JM; Klinger KW; Landes GM
    Genome Res; 1996 Jun; 6(6):525-37. PubMed ID: 8828041
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gross genomic rearrangement involving the TSC2-PKD1 contiguous deletion syndrome: characterization of the deletion event by quantitative polymerase chain reaction deletion assay.
    Boehm D; Bacher J; Neumann HP
    Am J Kidney Dis; 2007 Jan; 49(1):e11-21. PubMed ID: 17185137
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Developmental enamel defects in tuberous sclerosis: a clinical genetic marker?
    Flanagan N; O'Connor WJ; McCartan B; Miller S; McMenamin J; Watson R
    J Med Genet; 1997 Aug; 34(8):637-9. PubMed ID: 9279754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.